Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nektar Therapeutics Total Liabilities 2010-2024 | NKTR

Nektar Therapeutics total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  
Nektar Therapeutics Annual Total Liabilities
(Millions of US $)
2023 $267
2022 $344
2021 $438
2020 $461
2019 $572
2018 $433
2017 $421
2016 $481
2015 $492
2014 $405
2013 $524
2012 $451
2011 $409
2010 $431
2009 $473
Nektar Therapeutics Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $259
2024-06-30 $264
2024-03-31 $269
2023-12-31 $267
2023-09-30 $283
2023-06-30 $297
2023-03-31 $321
2022-12-31 $344
2022-09-30 $369
2022-06-30 $403
2022-03-31 $416
2021-12-31 $438
2021-09-30 $476
2021-06-30 $466
2021-03-31 $462
2020-12-31 $461
2020-09-30 $338
2020-06-30 $339
2020-03-31 $592
2019-12-31 $572
2019-09-30 $600
2019-06-30 $542
2019-03-31 $533
2018-12-31 $433
2018-09-30 $459
2018-06-30 $453
2018-03-31 $439
2017-12-31 $421
2017-09-30 $498
2017-06-30 $472
2017-03-31 $484
2016-12-31 $481
2016-09-30 $493
2016-06-30 $502
2016-03-31 $492
2015-12-31 $492
2015-09-30 $410
2015-06-30 $422
2015-03-31 $422
2014-12-31 $405
2014-09-30 $430
2014-06-30 $513
2014-03-31 $497
2013-12-31 $524
2013-09-30 $433
2013-06-30 $453
2013-03-31 $451
2012-12-31 $451
2012-09-30 $446
2012-06-30 $536
2012-03-31 $532
2011-12-31 $409
2011-09-30 $417
2011-06-30 $420
2011-03-31 $423
2010-12-31 $431
2010-09-30 $396
2010-06-30 $421
2010-03-31 $444
2009-12-31 $473
2009-09-30 $347
2009-06-30 $342
2009-03-31 $347
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.154B $0.090B
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others. The company's most lucrative deal is with Bristol-Myers, which provided the company with significant cash resources to support progress of its pipeline and share development costs for its lead candidate, bempegaldesleukin. Nektar recognizes product sales from its manufacturing and supply agreements with several pharma companies related to products developed using its PEGylation platform. The company also earns royalty payments from the sales of products using its technology platforms. Amgen's neutropenia drug, Neulasta is one of the drugs developed using Nektar's PEGylation platform.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.797B 29.55
Chugai Pharmaceutical (CHGCY) Japan $66.907B 26.06
Takeda Pharmaceutical (TAK) Japan $42.351B 8.81
Sandoz Group AG (SDZNY) Switzerland $20.614B 0.00
Merck (MKKGY) Germany $20.007B 17.92
Astellas Pharma (ALPMY) Japan $17.699B 16.30
United Therapeutics (UTHR) United States $16.641B 16.37
Summit Therapeutics (SMMT) United States $15.958B 0.00
Neurocrine Biosciences (NBIX) United States $15.256B 40.40
Shionogi (SGIOY) Japan $12.454B 12.48
Orion OYJ (ORINY) Finland $7.529B 21.17
Madrigal Pharmaceuticals (MDGL) United States $7.117B 0.00
Stevanato Group S.p.A (STVN) Italy $6.493B 42.04
Corcept Therapeutics (CORT) United States $6.447B 48.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.192B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.937B 7.84
Grifols, S.A (GRFS) Spain $4.813B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.652B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.858B 12.95
Recursion Pharmaceuticals (RXRX) United States $2.798B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.705B 16.17
Centessa Pharmaceuticals (CNTA) United Kingdom $2.236B 0.00
Soleno Therapeutics (SLNO) United States $2.128B 0.00
Hypermarcas (HYPMY) Brazil $1.926B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.920B 0.00
Indivior (INDV) United States $1.675B 6.83
BioCryst Pharmaceuticals (BCRX) United States $1.661B 0.00
Evotec AG (EVO) Germany $1.495B 0.00
Guardian Pharmacy Services (GRDN) United States $1.413B 0.00
ARS Pharmaceuticals (SPRY) United States $1.392B 0.00
Dyne Therapeutics (DYN) United States $1.378B 0.00
Xencor (XNCR) United States $1.318B 0.00
Ardelyx (ARDX) United States $1.298B 0.00
Ocular Therapeutix (OCUL) United States $1.233B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.165B 0.00
Harrow (HROW) United States $1.152B 0.00
Collegium Pharmaceutical (COLL) United States $1.046B 5.71
Enliven Therapeutics (ELVN) United States $1.019B 0.00
Bioventus (BVS) United States $0.851B 26.90
Relay Therapeutics (RLAY) United States $0.750B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.738B 0.00
Cronos Group (CRON) Canada $0.719B 0.00
USANA Health Sciences (USNA) United States $0.662B 12.27
Verve Therapeutics (VERV) United States $0.652B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.595B 0.00
Xeris Biopharma Holdings (XERS) United States $0.544B 0.00
Akebia Therapeutics (AKBA) United States $0.502B 0.00
Elite Pharmaceuticals (ELTP) United States $0.500B 0.00
Altimmune (ALT) United States $0.494B 0.00
Organogenesis (ORGO) United States $0.478B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.474B 0.00
ProKidney (PROK) United States $0.467B 0.00
Savara (SVRA) United States $0.458B 0.00
OmniAb (OABI) United States $0.448B 0.00
Siga Technologies (SIGA) United States $0.447B 5.22
KalVista Pharmaceuticals (KALV) United States $0.433B 0.00
Oruka Therapeutics (ORKA) United States $0.422B 0.00
Zevra Therapeutics (ZVRA) United States $0.420B 0.00
Tourmaline Bio (TRML) United States $0.419B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.396B 160.64
Esperion Therapeutics (ESPR) United States $0.372B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Aldeyra Therapeutics (ALDX) United States $0.308B 0.00
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.277B 16.46
CytoDyn (CYDY) United States $0.255B 0.00
Heron Therapeutics (HRTX) United States $0.254B 0.00
Avita Medical (RCEL) United States $0.246B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.237B 0.00
Larimar Therapeutics (LRMR) United States $0.237B 0.00
4D Molecular Therapeutics (FDMT) United States $0.231B 0.00
MediWound (MDWD) Israel $0.215B 0.00
Inhibikase Therapeutics (IKT) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.188B 0.00
Acrivon Therapeutics (ACRV) United States $0.173B 0.00
Lexeo Therapeutics (LXEO) United States $0.172B 0.00
Lyell Immunopharma (LYEL) United States $0.169B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.165B 0.00
Nanobiotix S.A (NBTX) France $0.163B 0.00
Silence Therapeutics (SLN) United Kingdom $0.157B 0.00
Champions Oncology (CSBR) United States $0.153B 0.00
Telomir Pharmaceuticals (TELO) United States $0.134B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.117B 0.00
Inotiv (NOTV) United States $0.114B 0.00
Cassava Sciences (SAVA) United States $0.111B 0.00
Achieve Life Sciences (ACHV) Canada $0.111B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.106B 0.00
ElectroCore (ECOR) United States $0.104B 0.00
Metagenomi (MGX) United States $0.099B 0.00
Fractyl Health (GUTS) United States $0.097B 0.00
Protara Therapeutics (TARA) United States $0.093B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Journey Medical (DERM) United States $0.082B 0.00
AleAnna (ANNA) United States $0.082B 0.00
Nutriband (NTRB) United States $0.081B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.079B 20.75
Avalo Therapeutics (AVTX) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Century Therapeutics (IPSC) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Regulus Therapeutics (RGLS) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
AlloVir (ALVR) United States $0.049B 0.00
FibroGen (FGEN) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
Surrozen (SRZN) United States $0.037B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 0.00
BioVie (BIVI) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Traws Pharma (TRAW) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Mannatech (MTEX) United States $0.023B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
PolyPid (PYPD) Israel $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
BioLineRx (BLRX) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00